← Back to All Filings

Natera CEO Steven Chapman Sells $545K in Routine 10b5-1 Trade

Low SignificanceSeptember 4, 2026 at 1:07:15 AM UTC

Natera, Inc.

$NTRA4CIK: 0001604821

Subscribe to track NTRA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Natera CEO Steven Chapman Sells $545K in Routine 10b5-1 Trade

Company: Natera, Inc. (NTRA) Form: 4 | Filed: 2026/09/04 Significance: Low

Insider: Chapman Steven Leonard Title: CEO AND PRESIDENT | Relationship: Director, Officer

Transaction: • Type: Sale • Shares: 1,698 • Price: $320.99 • Value: $545,041.02 • Owned After: 98,199

Key Insight: Routine Rule 10b5-1 scheduled disposition representing ~1.7% of the CEO's holdings and a negligible fraction of shares outstanding.

Market Context: NTRA trades at a large-cap valuation ($47.18B), making this transaction immaterial to overall float and company operations.

Comprehensive Analysis

SEC Filing Analysis: Natera, Inc. (NTRA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: CEO Steven Chapman disposed of 1,698 shares for approximately $545K under a pre-established Rule 10b5-1 trading plan.
  • Market Impact: Neutral; immaterial transaction relative to company capitalization and shares outstanding.

Company Information

FieldValue
CompanyNatera, Inc.
Ticker SymbolNTRA
CIK0001604821
IndustryServices-Medical Laboratories [8071]

Insider Information

FieldValue
NameChapman Steven Leonard
CIK0001711968
Title/PositionCEO AND PRESIDENT
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-09-01
Transaction CodeS (Open Market Sale)
Security TypeCommon Stock
Shares Involved1,698
Price Per Share$320.99
Total Value$545,041.02
Shares Owned After98,199
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$545,041.02
% of Market Cap0.0012%
Shares Transacted1,698
% of Shares Outstanding0.0012%
Post-Transaction Ownership98,199 shares (0.0686% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a large-cap issuer with a $47.18 billion market capitalization, a $545K transaction represents a negligible portion (<0.01%) of total value.
  • Ownership Concentration: The insider retains 98,199 direct shares, selling only ~1.7% of his direct position.
  • Dilution Impact: Non-dilutive secondary market disposition.
  • Transaction Significance: Low significance given the small transaction size relative to total shares outstanding and execution via an automated trading plan.

Market Impact Analysis

  • Stock Impact Prediction: Neutral. Pre-planned scheduled sales of minor magnitude rarely affect price discovery.
  • Expected Volume Impact: Immaterial compared to average daily trading volume.
  • Sentiment Indicator: Neutral.

Additional Context

  • Special Circumstances: The sale was executed pursuant to a Rule 10b5-1 trading plan adopted on December 11, 2023, and last amended on March 5, 2026.
Topics:#SECFiling#NTRA#Form4#InsiderTrading#InsiderSell#StockAlert#Biotech#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.